Related references
Note: Only part of the references are listed.FLT3 internal tandem duplication is associated with a high relapse rate and central nervous system involvement in acute promyelocytic leukemia cases: single institutional analysis
Haruko Tashiro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Therapeutic Advances in Acute Myeloid Leukemia
Alan Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling
J. Flach et al.
LEUKEMIA (2011)
Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features
Philippe Szankasi et al.
LEUKEMIA RESEARCH (2011)
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
Xiao-Jing Yan et al.
NATURE GENETICS (2011)
C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
Yue-Ying Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations
Harshabad Singh et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status
Susanne Schnittger et al.
BLOOD (2010)
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A. Ho et al.
BLOOD (2010)
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
Wen-Chien Chou et al.
BLOOD (2010)
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Wen-Chien Chou et al.
BLOOD (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
DNA methylation profiling in acute myeloid leukemia: from recent technological advances to biological and clinical insights
Rainer Claus et al.
FUTURE ONCOLOGY (2010)
Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML
F. Dicker et al.
LEUKEMIA (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
Ken I. Mills et al.
BLOOD (2009)
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia
Iveta Sarova et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Association of MLL amplification with poor outcome in acute myeloid leukemia
Robert W. Maitta et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly
Andrea Kuendgen et al.
CANCER TREATMENT REVIEWS (2009)
Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells
Daniela Meilinger et al.
EMBO REPORTS (2009)
Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup
Thomas Prebet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
A. Tefferi et al.
LEUKEMIA (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Susan P. Whitman et al.
BLOOD (2008)
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma
Ota Fuchs et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia
Kazunori Ohnishi
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Deregulated Ras signaling in developmental disorders: new tricks for an old dog
Suzanne Schubbert et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification
Laura Pasqualucci et al.
BLOOD (2006)
Use of the International System for Human Cytogenetic Nomenclature (ISCN)
Juan Ramon Gonzalez Garcia et al.
BLOOD (2006)
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia:: biological and clinical implications
C. G. Nyvold et al.
LEUKEMIA (2006)
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)
N. Boissel et al.
LEUKEMIA (2006)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years
DT Bowen et al.
BLOOD (2005)
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse
A Weltermann et al.
LEUKEMIA (2004)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML):: a survey of 110 cases from the French AML Intergroup
J Delaunay et al.
BLOOD (2003)
Cytogenetic heterogeneity of acute myeloid leukaemia (AML) with trilineage dysplasia: Japan Adult Leukaemia Study Group-AML 92 study
Y Miyazaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Rapid identification of frequent MLL rearrangements in hematologic malignancies by multiplex RT-PCR in a single assay
M Dupont
LEUKEMIA (2002)
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
T Pabst et al.
NATURE GENETICS (2001)
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor:: Evidence for its fusion with MLL in acute myeloid leukemia
PJ Kourlas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
